Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
You may think you've seen everything iOS 26 has to offer, but there's so much more to discover. With more than a decade of experience, Nelson covers Apple and Google and writes about iPhone and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results